BioNexus Gene Lab (BGLC) Asset Writedowns and Impairment (2023 - 2026)
BioNexus Gene Lab recorded quarterly Asset Writedowns and Impairment of $202497.0 in Q1 2026, up 193.77% quarter-over-quarter from -$215942.0 in Q4 2025, and up 404.68% year-over-year from $40124.0 in Q1 2025.
BioNexus Gene Lab's Asset Writedowns and Impairment history runs 5 years deep, the most recent figure standing at $202497.0 for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment rose 404.68% year-over-year to $202497.0; the TTM figure through Mar 2026 stood at $162373.0 (down 79.83% YoY), while the FY2024 annual figure was $883533.0, up 14164.34% from the prior year.
- Asset Writedowns and Impairment came in at $202497.0 for Q1 2026 at BioNexus Gene Lab, up from -$215942.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $760690.0 in Q4 2024 to a low of -$215942.0 in Q4 2025.
- A 5-year average of $107982.4 and a median of $4165.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment surged 37576.57% in 2024 and tumbled 128.39% in 2025, its largest moves.
- BioNexus Gene Lab's Asset Writedowns and Impairment stood at $4165.0 in 2022, then plunged by 51.52% to $2019.0 in 2023, then soared by 37576.57% to $760690.0 in 2024, then sank by 128.39% to -$215942.0 in 2025, then surged by 193.77% to $202497.0 in 2026.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $202497.0, -$215942.0, and $175818.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202,497.00 |
| Mar 31, 2026 | 202,497.00 |
| Dec 31, 2025 | 55,269.00 |
| Dec 31, 2025 | 55,269.00 |
| Sep 30, 2025 | 175,818.00 |
| Sep 30, 2025 | 175,818.00 |
| Dec 31, 2024 | -116,499.00 |
| Dec 31, 2024 | -116,499.00 |
| Sep 30, 2024 | 2,374.00 |
| Sep 30, 2024 | 2,374.00 |
| Dec 31, 2023 | -4,175.00 |
| Dec 31, 2023 | -4,175.00 |
| Sep 30, 2023 | 97.00 |
| Sep 30, 2023 | 97.00 |